What Are The Disadvantages Of Buying Organic Foods

Are you interested in making the switch to organic foods? If you are, you may want to first verify that you are making the right decision. You likely already know the many benefits to eating organic foods, as these benefits are often prominently displayed and advertised. With that being said, we rarely hear the disadvantages to eating organic foods.

One of the few disadvantages to eating organic foods is the cost. Do you know how much most organic foods costs? If not, you may first want to examine those costs before you make the decision to switch to organic foods. There is nothing worse than being blindsided or surprised with the cost of organic foods. After a close look, you will see that organic foods do cost a little bit more money, but that increase in cost can add up overtime.

Although the cost of organic food may turn you and other hopeful eaters away, it is also important to know that there are multiple ways in which you can go about saving money. For example, you can search for organic food sales at your local natural food stores or supermarkets. You stock up when you see those sales or choose to shop at a store that is know for their everyday low prices on organic foods. Organic food coupons can also be used. These coupons can be found online, with a standard internet search, in many stores, as well as in weekend newspapers.

In addition to costs, another disadvantage to eating organically is the limited selection of products that some individuals are faced with. Luckily, not everyone is faced with this organic food eating disadvantage. Often times, those who live in small cities and towns find it the hardest to buy organic foods. With that being said, it doesnt matter whether you live in a small town or a huge city, there are still a number of different ways that you can go about buying organic foods.

A great way to buy organic foods if you live in a small town is by going directly to the source, organic farmers. This is great way to get your organic fruits and vegetables, as many small towns now have organic farmers. You can also search for specialty organic food stores by using online business directories, your local phone book, or by asking those that you know for recommendations. The internet can also be used to shop online.

As previously stated, you can shop online to buy organic foods, but it is also important to know that there are a number of cons or downsides to doing so. This is mostly due in part to the requirements of shopping online. For example, a computer and internet connection is required to shop online. Many online shoppers also need to pay for shipping costs. Speaking of payments, most online food stores only accept credit or specific debit cards, namely those that can be processed as credit cards.

Although there are a number of disadvantages to eating organic foods, it is also important to remember the benefits or advantages to doing so as well. For starters, organic foods are all natural and safe to eat. There is no having to worry about potentially harmful chemicals, additives, and pesticides. Organic foods are also helping the environment and the economy.

Antihypertensives Market To 2016

In 2009, the global anti-hypertensive market was estimated to be worth $27.2 billion, representing a Compound Annual Growth Rate (CAGR) of 5.0% between 2002 and 2009. The market is forecast to reach $30 billion by 2016, indicating a CAGR of 1.5% between 2009 and 2016. The primary reason for slight and gradual growth in the market is the patent expiries of major blockbusters, which are expected to decrease the annual cost of therapy after 2007.

For Sample Pages, please click or add the below link to your browser:
https://www.gbiresearch.com/RequestSamplePages.aspx?ID=Antihypertensives-Market-to-2016-Generic-Erosion-Following-Patent-Expiry-of-Major-ARBs-to-Impact-the-Market&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report

The global anti-hypertensive market is expected to witness a series of patent expiries between 2007 and 2015, which includes most of the top selling blockbuster drugs in the anti-hypertensive market. The major drugs that are set to lose patent protection include Novartiss Diovan (2012), Sanofi Aventiss Avapro (2012), Novartiss Exforge (2012), Takeda/AstraZenecas Blopress/Atacand (2012), Pfizers Revatio (2012), Actelions Tracleer (2015), and United Therapeutics Remodulin (2014). All these drugs together accounted for more than $19.4 billion in revenues in 2009. Mercks Cozaar patent expired in April 2010. The sales of Cozaar for the year 2009 were $3.6 billion. Pfizers Norvasc, which was once the worlds most prescribed drug for hypertension and angina, saw a sales decline of 12% in 2009 due to genericization in 2007. Thus, the series of upcoming patent expiries in the hypertension as well as PAH markets are set to lead to a decline in the market in the near future. However, due to increased usage of fixed dose-combinations and the entry of generics, the market is expected to rise slightly after 2015.

The current anti-hypertensive pipeline does offer some promising novel products, such as SPP635, Actos, LCZ696, QT1571, ACT-293987, PS-433540, Macitentan and Riociguat, indicated for the treatment of hypertension and PAH. However, the revenues generated from these products are not expected to completely make up for the revenue losses due to patent expiries. Thus, the overall global anti-hypertensive market is expected to show flat growth during the forecast period.

GBI Research, a leading business intelligence provider, has released its latest research Antihypertensives Market to 2016 – Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global antihypertensive market. The report analyzes the markets for antihypertensive disorders in the US, the top five markets in Europe (the UK, Germany, France, Italy and Spain), and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

For further details, please click or add the below link to your browser:
https://www.gbiresearch.com/Report.aspx?ID=Antihypertensives-Market-to-2016-Generic-Erosion-Following-Patent-Expiry-of-Major-ARBs-to-Impact-the-Market&ReportType=Industry_Report&Title=Pharmaceuticals_and_Healthcare

Visit our report store: https://www.gbiresearch.com

For more details contact:
[emailprotected]
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782